Neovacs S.A. | Key People and Executives
Jean-Jacques Bertrand
Chairman
Miguel Sieler
Chief Executive Officer & Director
Jacques Banchereau
Director
Patrick Valroff
Independent Director
Arlene M. Morris
Independent Director
Jean-Jacques Bertrand
Chairman
Miguel Sieler
Chief Executive Officer & Director
Thérèse Croughs
Chief Medical Officer
Géraldine Grouard-Vogel
Chief Scientific Officer
Jacques Banchereau
Director
Charlène Masson
Head-Investor Relations & Communications
Nathalie Thomas-Pujol
Head-Regulatory Affairs
Patrick Valroff
Independent Director
Arlene M. Morris
Independent Director
| Address |
3-5, Impasse Reille
Paris Ile-de-France 75014
France
|
|
Employees
|
- |
| Website |
http://www.neovacs.fr |
| Updated |
07/08/2019 |
| Neovacs SA is a biotechnology company which engages in the development of active immunotherapies for treating auto-immune, inflammatory and cancerous diseases. It focuses on the development of Tumor Necrosis Factor-Kinoid for treating Crohn's disease and rheumatoid polyarthritis and Interferon-Kinoid for treating lupus. The company was founded by Daniel Zagury on April 16, 1993 and is headquartered in Paris, France. |
